Vizz being approved by the FDA marks a step in the right direction for treating vision loss in an accessible way.

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

For two decades, I had to douse my eyes with artificial tears to get through the day. Then I decided to see if I could shop ...

The US Food and Drug Administration has approved the first eye drop that can fix near vision, promising to help ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

Our data shows VIZZ (aceclidine 1.44%) received FDA approval in July 2025, positioning the once-daily, preservative-free ...

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours ...

The Food and Drug Administration has approved Vizz (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in ...

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

Vizz, a new FDA-approved eye drop, offers adults with age related near vision loss (presbyopia) a daily, non-surgical ...